ChemoCentryx
CCXI
#3560
Rank
โ‚ฌ3.20 B
Marketcap
44,60ย โ‚ฌ
Share price
0.00%
Change (1 day)
21.19%
Change (1 year)

Revenue for ChemoCentryx (CCXI)

Revenue in 2022 (TTM): โ‚ฌ33.46 Million

According to ChemoCentryx's latest financial reports the company's current revenue (TTM ) is โ‚ฌ31.91 Million. In 2021 the company made a revenue of โ‚ฌ28.16 Million a decrease over the revenue in the year 2020 that were of โ‚ฌ52.35 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ChemoCentryx from 2011 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚ฌ33.46 M18.79%
2021 โ‚ฌ28.16 M-46.2%
2020 โ‚ฌ52.35 M63.12%
2019 โ‚ฌ32.09 M-14.37%
2018 โ‚ฌ37.47 M-45.49%
2017 โ‚ฌ68.75 M532.45%
2016 โ‚ฌ10.87 M
2015 N/A
2014 N/A-100%
2013 โ‚ฌ4.38 M7.11%
2012 โ‚ฌ4.09 M-83.2%
2011 โ‚ฌ24.38 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Biogen
BIIB
โ‚ฌ8.63 B 26,958.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ51.16 B 160,233.33%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ36.33 B 113,751.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
โ‚ฌ41.20 B 129,023.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ79.04 B 247,612.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ30.85 B 96,596.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.85 B 168,679.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.39 B 44,996.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
โ‚ฌ55.10 B 172,574.73%๐Ÿ‡บ๐Ÿ‡ธ USA